В.Л. Лобашова, И.В. Патеюк, Ю.В. Дыдышко, С.С. Стебунов, А.А. Качан, М.В. Елесина, А.Р. Заркуа, Н.В. Шпигун
Учреждение образование «Белорусский государственный медицинский университет», Минск, Республика Беларусь, Государственное учреждение «Минский научно-практический центр хирургии, трансплантологии и гематологии», Минск, Республика Беларусь
Кардиоваскулярная патология является ведущей причиной смертности населения во всем мире, а ожирение и ассоциированные с ним метаболические нарушения одним из основных факторов риска развития и прогрессирования сердечно-сосудистых заболеваний. Для большинства пациентов с ожирением изменение образа жизни на длительный период
времени представляется трудновыполнимым, особенно у коморбидного пациента. Метаболическая хирургия в настоящее время признана эффективным способом лечения морбидного ожирением, сокращая частоту развития и риск серьезных последствий сопутствующих ожирению заболеваний.
Цель данной статьи состояла в оценке влияния метаболической хирургии на сердечно-сосудистые события и другие ассоциированные состояния у пациентов с ожирением. В работе приведена актуальная информация о современных оперативных вмешательствах (шунтирование, продольная резекция желудка, мини-гастрошунтирование и бандажирование желудка). Представлены данные об эффективности метаболических операций в лечении ожирения, артериальной гипертензии и дислипидемии.
Также обсуждается влияние бариатрии на ремиссию сахарного диабета 2 типа.
ключевые слова: сердечно-сосудистый риск, ожирение, морбидное ожирение. метаболическая хирургия, бариатрия, сахарный диабет, артериальная гипертензия, дислипидемия.

для цитирования: В.Л. Лобашова, И.В. Патеюк, Ю.В. Дыдышко, С.С. Стебунов, А.А. Качан, М.В. Елесина, А.Р. Заркуа, Н.В. Шпигун. Сердечно-сосудистый риск у коморбидных пациентов после метаболической коррекции. Неотложная кардиология и кардиоваскулярные риски, 2023, Т. 7, № 2, С. 2041–2049.

CARDIOVASCULAR RISK IN COMORBID PATIENTS AFTER METABOLIC SURGERY
V. Labashova, I. Pateyuk, Y. Dydyshko, S. Stebunov, A. Kachan, M. Yelesina, A. Zarqua, N. Shpigun
Cardiovascular pathology is the leading cause of mortality in the world
as well as obesity and associated metabolic disorders are one of the
main risk factors for the development and progression of cardiovascular
diseases. For most obese patients changing lifestyle for a long period
of time seems difficult especially in case of comorbidity. Metabolic surgery
is currently recognized as an effective way to treat morbid obesity, reducing
the incidence and risk of serious consequences of obesity-related diseases. The aim of this article was to evaluate the effect of metabolic surgery on cardiovascular
events and other associated conditions in obese patients. The article provides
up-to-date information on modern surgical interventions (gastric bypass, sleeve
gastrectomy, mini-gastric bypass and gastric banding). We represent data
on the effectiveness of metabolic surgery in obesity, hypertension and dyslipidemia.
The effect of bariatric surgery on the remission of type 2 diabetes mellitus
is also discussed.
keywords: cardiovascular risk, obesity, morbid obesity, metabolic surgery, bariatric surgery, diabetes mellitus, hypertension, dyslipidemia

for references: . V. Labashova, I. Pateyuk, Y. Dydyshko, S. Stebunov, A. Kachan, M. Yelesina, A. Zarqua, N. Shpigun. Cardiovascular risk in comorbid patients after metabolic surgery. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2023, vol. 7, no. 2, pp. 2041–2049.

Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A.,
Read J.M., Dondelinger F. [et al.] Features of 20 133 UK patients in hospital with COVID-19
using the ISARIC WHO Clinical Characterisation Protocol: prospective observational
cohort study. BMJ, 2020, vol. 369, pp. m1985. doi: 10.1136/bmj.m1985.
2. Cariou B., Hadjadj S., Wargny M., Pichelin M., Al-Salameh A., Allix I., Amadou C.,
Arnault G., Baudoux F., Bauduceau B., Borot S. [et al.] Phenotypic characteristics and
prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia, 2020, vol. 63, no. 8, pp. 1500–1515.
3. Rubino F., Cohen R.V., Mingrone G., le Roux C.W., Mechanick J.I., Arterburn D.E., Vidal J.,
Alberti G., Amiel S.A., Batterham R.L., Bornstein S., Chamseddine G. [et al.] Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients
and prioritisation of access to surgery. Lancet Diabetes Endocrinol, 2020, vol. 8,
no. 7, pp. 640–648. doi: 10.1016/S2213-8587(20)30157-1.
4. Hussain A., Mahawar K., El-Hasani S. The impact of COVID-19 pandemic on obesity
and bariatric surgery. Obes Surg, 2020, vol. 30, no. 8, pp. 3222–3223. doi: 10.1007/
s11695-020-04637-7.
5. Angelantonio E.D., Bhupathiraju S.N., Wormser D., Gao P., Kaptoge S., Berrington
de Gonzalez A., Cairns B.J., Huxley R. [et al.] The Global BMI Mortality Collaboration
(Body-mass index and all-cause mortality: individual participant-data metaanalysis of 239 prospective studies in four continents. Lancet, 2016, vol. 388, pp. 776–786.
doi: 10.1016/S0140-6736(16)30175-1.
6. Ivanova A.YU., Dolgalyov I.V. Vliyanie izbytochnoj massy tela i ozhireniya na smertnost’ (po rezul’tatam 27-letnego prospektivnogo issledovaniya) [Impact of overweight and obesity on mortality (according to the results of a 27-year prospective
study)]. Profilakticheskaya medicina, 2017, vol. 20, no. 3, pp. 34–39. (in Russian).
7. Aune D., Sen A., Prasad M., Norat T., Janszky I., Tonstad S., Romundstad P., Vatten
L.J. BMI and all cause mortality: systematic review and non-linear dose-response
meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million
participants. BMJ, 2016, vol. 353, pp. i2156.
8. Sonmez A., Yumuk V., Haymana C., Demirci I., Barcin C., Kıyıcı S., Güldiken S., Örük G.,
Ozgen Saydam B. [et al.] Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic
Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Obes Facts,
2019, vol. 12, no. 2, pp. 167–178.
9. Field A. E., Manson J. E., Laird N., Williamson D.F., Willett W.C., Colditz G.A. Weight
cycling and the risk of developing type 2 diabetes among adult women in the United
States. Obesity research, 2004, vol. 12, no. 2, pp. 267-274.
10. Powell-Wiley T. M., Poirier P., Burke L.E., Després J.P., Gordon-Larsen P., Lavie C.J.,
Lear S.A., Ndumele C.E., Neeland I.J., Sanders P., St-Onge M.P. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 2021, vol. 143, no. 21, pp. e984-e1010.
11. Currie A.C., Askari A., Newton R.C., Albon L., Hawkins W., Slater G., Pring C.M. Regional variation in unmet need for metabolic surgery in England: a retrospective,
multicohort analysis. Obes Surg, 2021, vol. 31, no. 1, pp. 439–444. doi: 10.1007/
s11695-020-04874-w.
12. Dixon J.B. Regional differences in the coverage and uptake of bariatric-metabolic
surgery: a focus on type 2 diabetes. Surg Obes Relat Dis, 2016, vol. 12, no. 6,
pp. 1171–1177. doi: 10.1016/j.soard.2015.11.027.
13. Welbourn R., Dixon J., Barth J.H., Finer N., Hughes C.A., le Roux C.W., Wass J.
NICE-accredited commissioning guidance for weight assessment and management
clinics: a model for a specialist multidisciplinary team approach for people
with severe obesity. Obes Surg, 2016, vol. 26, no. 3, pp. 649–659. doi: 10.1007/
s11695-015-2041-8.
14. Welbourn R., Hopkins J., Dixon J.B., Finer N., Hughes C., Viner R., Wass J. Commissioning guidance for weight assessment and management in adults and children
with severe complex obesity. Obes Rev, 2018, vol. 19, no. 1, pp. 14–27. doi: 10.1111/
obr.12601.
15. Kashchenko V.A., Ctrizheleckij V.V., Nejmark A.E. [et al.] Bariatricheskaya hirurgiya
[Bariatrická chirurgia] : ucheb.-metod. posobie. SPb., 2020, 48 s. : il. (in Russian).
16. O’Brien P.E., Hindle A., Brennan L., Skinner S., Burton P., Smith A., Crosthwaite G.,
Brown W. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and
Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures
and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding.
Obes Surg, 2019, vol. 29, no. 1, pp. 3-14. doi: 10.1007/s11695-018-3525-0.
17. Welbourn R., Hollyman M., Kinsman R., Dixon J., Liem R., Ottosson J., Ramos A.,
Våge V., Al-Sabah S., Brown W., Cohen R., Walton P., Himpens J. Bariatric Surgery
Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth
IFSO Global Registry Report 2018. Obes. Surg., 2019, vol. 29, no. 3, pp. 782–795.
18. Stenberg E., Cao Y., Marsk R., Sundbom M., Jernberg T., Näslund E. Association
between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study. PLoS Medicine, 2020, vol. 17, no. 9,
pp. e1003307.
19. McGlone E.R., Carey I., Veličković V., Chana P., Mahawar K., Batterham R.L., Hopkins J.,
Walton P., Kinsman R., Byrne J., Somers S., Kerrigan D., Menon V., Borg C., Ahmed A.,
Sgromo B., Cheruvu C., Bano G., Leonard C., Thom H., le Roux C.W., Reddy M.,
Welbourn R., Small P., Khan O.A. Bariatric surgery for patients with type 2 diabetes
mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses. PLoS
Med, 2020, vol. 17, no. 12, pp. e1003228. doi: 10.1371/journal.pmed.1003228.
20. Fink J., Seifert G., Blüher M., Fichtner-Feigl S., Marjanovic G. Obesity Surgery. Dtsch
Arztebl Int, 2022, vol. 119, no. 5, pp. 70–80. doi: 10.3238/arztebl.m2021.0359.
21. Keating C.L., Dixon J.B., Moodie M.L., Peeters A., Bulfone L., Maglianno D.J., O’Brien P.E.
Cost-effectiveness of surgically induced weight loss for the management of type 2
diabetes: modeled lifetime analysis. Diabetes Care, 2009, vol. 32, no. 4, pp. 567–574.
doi: 10.2337/dc08-1749. Epub 2009.
22.Currie A.C., Askari A., Fangueiro A., Mahawar K. Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes. Obes Surg, 2021,
vol. 31, no. 10, pp. 4528–4541.
23. Fisher D.P., Johnson E., Haneuse S., Arterburn D., Coleman K.J., O’Connor P.J., O’Brien
R., Bogart A., Theis M.K., Anau J., Schroeder E.B., Sidney S. Association Between
Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA, 2018, vol. 320, no. 15, pp. 1570–1582. doi:
10.1001/jama.2018.14619.
24. Sheng B., Truong K., Spitler H., Zhang L., Tong X., Chen L. The Long-Term Effects
of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular
Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg,
2017, vol. 27, no. 10, pp. 2724–2732. doi: 10.1007/s11695-017-2866-4.
25. Johnson B.L., Blackhurst D.W., Latham B.B., Cull D.L.., Bour E.S., Oliver T.L., Williams B.,
Taylor S.M., Scott J.D. Bariatric surgery is associated with a reduction in major
macrovascular and microvascular complications in moderately to severely obese
patients with type 2 diabetes mellitus. J Am Coll Surg, 2013, vol. 216, no. 4,
pp. 545–556. doi: 10.1016/j.jamcollsurg.2012.12.019.
26. Anveden Å., Taube M., Peltonen M., Jacobson P., Andersson-Assarsson J.C., Sjöholm K.,
Svensson P.A. Long-term incidence of female-specific cancer after bariatric surgery
or usual care in the Swedish Obese Subjects Study. Gynecologic Oncology, 2017,
vol. 145, no. 2, pp. 224–229.
27. Keating C.L., Dixon J.B., Moodie M.L., Peeters A., Bulfone L., Maglianno D.J., O’Brien P.E.
Cost-ef fectiveness of surgically induced weight loss for the management
of type 2 diabetes: modeled lifetime analysis. Diabetes care, 2009, vol. 32, no. 4,
pp. 567–574.
28.Eisenberg D., Shikora S.A., Aarts E., Aminian A., Angrisani L., Cohen R.V., de Luca M.,
Faria S.L. [et al.] 2022 American Society for Metabolic and Bariatric Surgery (ASMBS)
and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO):
Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis, 2022, vol. 18,
no. 12, pp. 1345–1356.
29. Berkovskaya M.A., Kushkhanashkhova D.A., Sych Yu.P., Fadeev V.V. Sostoyanie
fosforno-kal’cievogo obmena u pacientov posle bariatricheskih operacij i rol’ vospolneniya deficita vitamina D v profilaktike i lechenii posleoperacionnyh kostno-metabolicheskih narushenij [Characteristics of calcium and phosphorous metabolism
in patients after bariatric surgery and the role of vitamin d supplementation
in the prevention and treatment of postoperative bone and mineral disorders].
Obesity and metabolism, 2020, vol. 17, no. 1, pp. 73–81. (in Russian).
30.Kim E.I., Ershova E.V., Mazurina N.V., Komshilova K.A. Postbariatricheskie gipoglikemii: vzglyad endokrinologa [A view at postbariatric hypoglycemia by endocrinologist]. Obesity and metabolism, 2021, vol. 18, no. 4, pp. 471–483. (in Russian).
31. Mulita F., Lampropoulos C., Kehagias D., Verras G.I., Tchabashvili L., Kaplanis C., Liolis E.,
Iliopoulos F. [et al.] Long-term nutritional deficiencies following sleeve gastrectomy:
a 6-year single-centre retrospective study. Prz. Menopauzalny, 2021, vol. 20, no. 4,
pp. 170–176.
Формат файла: pdf (511.23 Кб)